Skip to main content
Veterinary Medicines

Suvaxyn M.HYO inaktywowany antygen Mycoplasma hyopneumoniae 2x10^9,0 MHDCE*.(*) Mycoplasma hyopneumoniae DNA cell equivalents - ekwiwalenty komórek M.hyopneumoniae obliczone na podstawie zawartości DNA. Zawiesina do wstrzykiwań

Authorised
  • Mycoplasma hyopneumoniae, Inactivated

Product identification

Medicine name:
Suvaxyn M.HYO inaktywowany antygen Mycoplasma hyopneumoniae 2x10^9,0 MHDCE*.(*) Mycoplasma hyopneumoniae DNA cell equivalents - ekwiwalenty komórek M.hyopneumoniae obliczone na podstawie zawartości DNA. Zawiesina do wstrzykiwań
Active substance:
  • Mycoplasma hyopneumoniae, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, Inactivated
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1597
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 13/10/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 13/10/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 13/10/2025